Atreo

Atreo was founded with the mission to revolutionize the client experience in the realm of Randomization and Trial Supply Management (RTSM). The company focuses on providing innovative, customizable RTSM solutions that can be rapidly deployed within 1-2 weeks. Atreo's services cater to a diverse range of clients, from emerging biotech firms to top-tier pharmaceutical companies and Contract Research Organizations (CROs). Their modern and collaborative System Design Experience allows clients to explore and refine fully functional RTSM systems tailored to their specific protocols from day one.

Notable figures affiliated with Atreo include a team with extensive experience across all aspects of RTSM, Clinical Supplies, and Clinical Trials project delivery. The company has supported over 1000 clinical trials, demonstrating significant expertise and impact in the industry. Key achievements include offering 10x testing coverage compared to legacy RTSM providers and unmatched system configurability and agility post-launch. Atreo's innovative approach has set a new standard for client experience in clinical trial management, making a substantial impact on the efficiency and effectiveness of clinical trials globally.